Maedi-Visna_NP Virus_NP and_CC Caprine_NP Arthritis_NP Encephalitis_NP Virus_NP Genomes_NP Encode_NP a_DT Vpr-Like_JJ but_CC No_DT Tat_NP Protein_NP A_DT small_JJ open_JJ reading_NN frame_NN (_( ORF_NP )_) in_IN maedi-visna_NN virus_NN (_( MVV_NP )_) and_CC caprine_JJ arthritis_NN encephalitis_NN virus_NN (_( CAEV_NP )_) was_VBD initially_RB named_VBN "_`` tat_NN "_'' by_IN analogy_NN with_IN a_DT similarly_RB placed_VBN ORF_NP in_IN the_DT primate_NN lentiviruses_NNS ._SENT The_DT encoded_VBD "_`` Tat_NP "_'' protein_NN was_VBD ascribed_VBN the_DT function_NN of_IN up_RB regulation_NN of_IN the_DT viral_JJ transcription_NN from_IN the_DT long_JJ terminal_NN repeat_NN (_( LTR_NP )_) promoter_NN ,_, but_CC we_PP have_VBP recently_RB reported_VBN that_IN MVV_NP and_CC CAEV_NP Tat_NP proteins_NNS lack_VBP trans-activation_NN function_NN activity_NN under_IN physiological_JJ conditions_NNS (_( S._NP Villet_NP ,_, C._NP Faure_NP ,_, B._NP Bouzar_NP ,_, G._NP Verdien_NP ,_, Y._NP Chebloune_NP ,_, and_CC C._NP Legras_NP ,_, Virology_NP 307:317-327_CD ,_, 2003_CD )_) ._SENT In_IN the_DT present_JJ work_NN ,_, we_PP show_VBP that_IN MVV_NP Tat_NP localizes_VBZ to_TO the_DT nucleus_NN of_IN transfected_JJ cells_NNS ,_, probably_RB through_IN the_DT action_NN of_IN a_DT nuclear_JJ localization_NN signal_NN in_IN its_PP$ C-terminal_JJ portion_NN ._SENT We_PP also_RB show_VBP that_IN ,_, unlike_IN the_DT human_JJ immunodeficiency_NN virus_NN (_( HIV_NP )_) Tat_NP protein_NN ,_, MVV_NP Tat_NP was_VBD not_RB secreted_VBN into_IN the_DT medium_NN by_IN transfected_JJ human_JJ or_CC caprine_JJ cells_NNS in_IN the_DT absence_NN of_IN cell_NN lysis_NN but_CC that_IN ,_, like_IN the_DT primate_NN accessory_JJ protein_NN Vpr_NP ,_, MVV_NP and_CC CAEV_NP Tat_NP proteins_NNS were_VBD incorporated_VBN into_IN viral_JJ particles_NNS ._SENT In_IN addition_NN ,_, analysis_NN of_IN the_DT primary_JJ protein_NN structures_NNS showed_VBD that_IN small-ruminant_JJ lentivirus_NNS (_( SRLV_NP )_) Tat_NP proteins_NNS are_VBP more_RBR similar_JJ to_TO the_DT HIV_NP type_NN 1_CD (_( HIV-1_NP )_) Vpr_NP protein_NN than_IN to_TO HIV-1_NP Tat_NP ._SENT We_PP also_RB demonstrate_VBP a_DT functional_JJ similarity_NN between_IN the_DT SRLV_NP Tat_NP proteins_NNS and_CC the_DT HIV-1_NP Vpr_NP product_NN in_IN the_DT induction_NN of_IN a_DT specific_JJ G2_NP arrest_NN of_IN the_DT cell_NN cycle_NN in_IN MVV_NP Tat-transfected_NP cells_NNS ,_, which_WDT increases_VBZ the_DT G2/G1_JJ ratio_NN 2.8-fold_NN ._SENT Together_RB ,_, these_DT data_NNS strongly_RB suggest_VBP that_IN the_DT tat_NN ORF_NP in_IN the_DT SRLV_NP genomes_NNS does_VBZ not_RB code_VB for_IN a_DT regulatory_JJ transactivator_NN of_IN the_DT LTR_NP but_CC ,_, rather_RB ,_, for_IN a_DT Vpr-like_JJ accessory_JJ protein_NN ._SENT Lentiviruses_NNS comprise_VBP a_DT genus_NN of_IN complex_JJ ,_, nononcogenic_JJ retroviruses_NNS that_WDT infect_VBP diverse_JJ mammalian_JJ hosts_NNS ,_, including_VBG primates_NNS (_( human_JJ immunodeficiency_NN virus_NN [_SYM HIV_NP ]_SYM and_CC simian_JJ immunodeficiency_NN virus_NN )_) ,_, carnivores_NNS (_( feline_JJ immunodeficiency_NN virus_NN )_) ,_, and_CC ungulates_NNS (_( equine_JJ infectious_JJ anemia_NN virus_NN ,_, bovine_JJ immunodeficiency_NN virus_NN ,_, and_CC the_DT small-ruminant_JJ lentiviruses_NNS [_SYM SRLV_NP ]_SYM )_) ._SENT In_IN addition_NN to_TO the_DT three_CD essential_JJ retroviral_JJ genes_NNS ,_, gag_NN ,_, pol_NN ,_, and_CC env_NP ,_, lentiviruses_NNS carry_VBP a_DT variable_JJ number_NN of_IN regulatory_JJ and_CC accessory_JJ genes_NNS ,_, most_JJS of_IN which_WDT are_VBP situated_VBN between_IN the_DT end_NN of_IN pol_NN and_CC the_DT beginning_NN of_IN env_NP ._SENT The_DT most_RBS complex_JJ of_IN these_DT viruses_NNS ,_, HIV_NP type_NN 1_CD (_( HIV-1_NP )_) ,_, encodes_VBZ three_CD regulatory_JJ genes_NNS ,_, tat_NN ,_, rev_NN ,_, and_CC vif_NN ,_, and_CC three_CD accessory_JJ genes_NNS ,_, vpu_NP ,_, vpr_NN ,_, and_CC nef_NN ._SENT The_DT three_CD conserved_VBD open_JJ reading_NN frames_NNS found_VBN between_IN pol_NN and_CC env_NN in_IN the_DT SRLVs_NP maedi-visna_NN virus_NN (_( MVV_NP )_) and_CC caprine_JJ arthritis-encephalitis_NN virus_NN (_( CAEV_NP )_) have_VBP classically_RB been_VBN assigned_VBN to_TO the_DT regulatory_JJ genes_NNS tat_NN ,_, rev_NN ,_, and_CC vif_NN ._SENT Some_DT MVV-infected_JJ sheep_NN progress_NN to_TO a_DT stage_NN of_IN chronic_JJ debilitating_JJ disease_NN affecting_VBG mainly_RB the_DT lungs_NNS (_( progressive_JJ interstitial_JJ pneumonia_NN )_) and_CC the_DT central_JJ nervous_JJ system_NN (_( progressive_JJ demyelinating_NN encephalomyelitis_NN )_) many_JJ years_NNS after_IN infection_NN ._SENT Goats_NNS infected_VBN by_IN the_DT related_JJ CAEV_NP can_MD develop_VB leukoencephalomyelitis_NNS (_( young_JJ kids_NNS )_) or_CC chronic_JJ arthritis_NN and_CC mastitis_NN (_( adult_NN animals_NNS )_) ._SENT In_IN vivo_RB ,_, MVV_NP and_CC CAEV_NP chiefly_RB replicate_VB in_IN cells_NNS of_IN the_DT monocyte/macrophage_NN lineage_NN ,_, and_CC viral_JJ replication_NN has_VBZ been_VBN found_VBN to_TO be_VB dependent_JJ on_IN the_DT differentiation_NN of_IN monocytes_NNS into_IN macrophages_NNS ._SENT Unlike_IN the_DT primate_NN and_CC feline_JJ lentiviruses_NNS ,_, MVV_NP and_CC CAEV_NP do_VBP not_RB cause_VB immune_JJ deficiency_NN in_IN their_PP$ infected_JJ hosts_NNS ._SENT This_DT property_NN correlates_VBZ with_IN their_PP$ inability_NN to_TO cause_VB productive_JJ infection_NN of_IN CD4+_NP T_NN lymphocytes_NNS ._SENT Some_DT studies_NNS have_VBP reported_VBN an_DT increase_NN in_IN the_DT expression_NN of_IN genes_NNS under_IN the_DT control_NN of_IN the_DT MVV_NP or_CC CAEV_NP long_JJ terminal_NN repeat_NN (_( LTR_NP )_) or_CC a_DT stabilization_NN of_IN the_DT corresponding_JJ mRNA_NN in_IN the_DT presence_NN of_IN the_DT corresponding_JJ Tat_NP peptide_NN ,_, but_CC the_DT increases_NNS in_IN the_DT levels_NNS of_IN activity_NN were_VBD inconstant_JJ and_CC often_RB low_JJ ,_, ranging_VBG from_IN 1.6-fold_NN to_TO 46-fold_NN ._SENT We_PP have_VBP recently_RB compared_VBN the_DT transactivation_NN activities_NNS of_IN HIV-1_NP Tat_NP with_IN Tat_NP proteins_NNS from_IN MVV_NP and_CC CAEV_NP on_IN their_PP$ homologous_JJ LTRs_NN in_IN different_JJ cell_NN types_NNS ,_, including_VBG macrophages_NNS ,_, from_IN natural_JJ host_NN species_NNS and_CC found_VBD little_RB or_CC no_DT transactivation_NN by_IN SRLV_NP Tat_NP proteins_NNS under_IN conditions_NNS in_IN which_WDT the_DT HIV-1_NP Tat_NP produced_VBD a_DT 60-fold_JJ increase_NN in_IN expression_NN of_IN the_DT reporter_NN gene_NN ._SENT We_PP concluded_VBD that_DT transactivation_NN of_IN the_DT homologous_JJ LTR_NP was_VBD unlikely_JJ to_TO be_VB the_DT principal_JJ function_NN of_IN the_DT SRLV_NP Tat_NP proteins_VBZ ._SENT In_IN the_DT present_JJ study_NN ,_, we_PP attempted_VBD to_TO identify_VB the_DT possible_JJ natural_JJ activities_NNS of_IN the_DT SRLV_NP Tat_NP proteins_NNS through_IN an_DT analysis_NN of_IN their_PP$ cellular_JJ localization_NN and_CC potential_JJ function_NN ._SENT In_IN transfected_JJ cells_NNS ,_, the_DT SRLV_NP Tat_NP protein_NN is_VBZ strongly_RB concentrated_VBN in_IN the_DT nucleus_NN ,_, and_CC this_DT localization_NN depends_VBZ on_IN the_DT presence_NN of_IN signals_NNS on_IN the_DT C-terminal_JJ portion_NN of_IN the_DT protein_NN ._SENT In_IN contrast_NN to_TO HIV-1_NP Tat_NP ,_, the_DT SRLV_NP Tat_NP protein_NN is_VBZ never_RB found_VBN in_IN the_DT culture_NN supernatant_JJ of_IN intact_JJ transfected_JJ human_JJ or_CC ovine_JJ cells_NNS ._SENT It_PP is_VBZ ,_, however_RB ,_, incorporated_VBN into_IN both_DT MVV_NP and_CC CAEV_NP virus_NN particles_NNS released_VBN from_IN productively_RB infected_JJ cells_NNS ._SENT Since_IN all_PDT these_DT characteristics_NNS are_VBP shared_VBN by_IN the_DT Vpr_NP protein_NN of_IN HIV-1_NP ,_, we_PP tested_VBD the_DT SRLV_NP Tat_NP proteins_NNS for_IN their_PP$ ability_NN to_TO mediate_VB an_DT important_JJ function_NN of_IN HIV-1_NP Vpr_NP ,_, namely_RB ,_, cell_NN cycle_NN arrest_NN in_IN the_DT G2_NP phase_NN ._SENT We_PP found_VBD that_IN the_DT ratio_NN of_IN cells_NNS in_IN G2_NP to_TO those_DT in_IN G1_NP increased_VBD 2.8-fold_NN in_IN unsynchronized_JJ cultures_NNS transfected_VBN with_IN tat_NN from_IN MVV_NP compared_VBN to_TO that_DT in_IN mock-transfected_JJ controls_NNS ._SENT Taken_VBN together_RB ,_, the_DT results_NNS presented_VBN in_IN this_DT paper_NN clearly_RB show_VBP that_IN the_DT lentiviruses_NNS of_IN sheep_NN and_CC goats_NNS do_VBP not_RB encode_VB a_DT potent_JJ transactivator_NN of_IN their_PP$ own_JJ LTRs_NN but_CC ,_, rather_RB ,_, a_DT protein_NN with_IN functions_NNS closely_RB related_VBN to_TO those_DT of_IN the_DT Vpr_NP proteins_NNS of_IN the_DT primate_NN lentiviruses_NNS ._SENT Plasmid_NP constructs_VBZ ._SENT |_SYM Plasmids_NNS directing_VBG the_DT expression_NN of_IN green_JJ fluorescent_JJ protein_NN (_( GFP_NP )_) linked_VBD to_TO the_DT MVV_NP Tat_NP peptide_NN or_CC to_TO the_DT 5_CD '_POS or_CC 3_CD '_'' portions_NNS of_IN the_DT molecule_NN were_VBD constructed_VBN by_IN inserting_VBG the_DT relevant_JJ genetic_JJ elements_NNS between_IN the_DT XhoI_NP and_CC HindIII_NP sites_NNS of_IN pEGFP_NN (_( Clontech_NP ,_, Hampshire_NP ,_, United_NP Kingdom_NP )_) ._SENT The_DT complete_JJ tat_NN sequence_NN was_VBD amplified_VBN from_IN the_DT p8Xsp5-RK1_JJ (_( KV-1772_NP )_) recombinant_JJ genomic_JJ plasmid_NN with_IN primers_NNS UC1-tot_NP and_CC LC1-tot_NP ,_, and_CC the_DT truncated_JJ sequences_NNS were_VBD generated_VBN by_IN using_VBG LC1-5_NP '_POS in_IN place_NN of_IN LC1-tot_NP or_CC UC1-3_NP '_POS in_IN place_NN of_IN UC1-tot_NP ._SENT A_DT FLAG_NP epitope-labeled_JJ Tat_NP protein_NN from_IN HIV-1_NP and_CC equivalent_JJ fusion_NN proteins_NNS from_IN MVV_NP and_CC CAEV_NP were_VBD expressed_VBN from_IN plasmids_NNS constructed_VBN by_IN first_RB inserting_VBG a_DT 633-bp_JJ BglII-PstI_NP fragment_NN containing_VBG the_DT cytomegalovirus_NN promoter_NN from_IN pUT535_NN (_( Cayla_NP ,_, Montpelier_NP ,_, France_NP )_) into_IN plasmid_NP BSK+_NP (_( Stratagene_NP ,_, Amsterdam_NP ,_, The_DT Netherlands_NPS )_) and_CC then_RB adding_VBG a_DT 158-bp_JJ SalI-ApaI_NP fragment_NN containing_VBG the_DT simian_JJ virus_NN 40_CD (_( SV40_NP )_) polyadenylation_NN signal_NN from_IN pUT614_NN (_( Cayla_NP )_) to_TO create_VB the_DT BSK-CMV-pA_NP vehicle_NN ._SENT The_DT HIV-1_NP Tat_NP sequence_NN and_CC the_DT SRLV_NP equivalents_NNS were_VBD tagged_VBN with_IN the_DT FLAG_NP epitope_NN by_IN amplification_NN from_IN pSG5_NP Tat_NP (_( kindly_RB supplied_VBN by_IN L._NP Gazzolo_NP )_) for_IN HIV-1_NP ,_, from_IN p8Xsp5-RK1_NN for_IN MVV_NP ,_, or_CC from_IN pK9_JJ Kb_NP for_IN CAEV_NP with_IN 5_CD '_POS primers_NNS containing_VBG the_DT FLAG_NP coding_VBG sequence_NN (_( H-Flag5_NP '_POS ,_, V-Flag5_NP '_POS ,_, and_CC C-Flag5_NP '_POS ,_, respectively_RB )_) and_CC the_DT relevant_JJ 3_CD '_POS primers_NNS (_( Tat_NP HIV3_NP ,_, LC1tot_NP ,_, and_CC Tat_NP 04_CD ,_, respectively_RB )_) as_RB follows_VBZ :_: UC1-tot_NP ,_, 5'CCCTCGAGGCGAAGAAGTACCAAGAAG3_JJ '_'' ;_: LC1-tot_NP ,_, 5'CCAAGCTTATCACAGTTCAACATT_NP TC3_NP '_'' ;_: LC1-5_NP '_POS ,_, 5'CCAAGCTTTCATTCGCCAGGTACTCTT_NP 3_CD '_'' ;_: UC1-3_NP '_POS ,_, 5'CCCTCGAGGCAGACTACAACGATGGCT_JJ 3_CD '_'' ;_: C-Flag5_NP '_POS ,_, 5'GGAATTCATGGACTACAAGGACGACGATGACAGTGAAGAACTGCCTCAAAGAAGGGAGACACATCCAGAAGAACTTGTAAGGAACGTACGGGAAAGAGAAAG3_JJ '_'' ;_: Tat_NP 04_CD ,_, 5'CCAAGCTTGATTATGTTCCCCACCC3_JJ '_'' ;_: V-Flag5_NP '_POS ,_, 5'GGAATTCATGGACTACAAGGACGACGATGACAAGGAAGAAGTACAAGAAGAAGCCAGGAGGCTTAGTAGAAGTAGAGGGAGTATTTCAATTTTATGAAGA3_JJ '_'' ;_: H-Flag5_NP '_POS ,_, 5'TGAATTCATGGACTACAAGGACGACGATGACAAGGAGCCAGTAGATCCTAGCTAGAGCCCTGGAAGCATCCAGGAAGT_NP CAGCCTAAAACTGCTTGTACCACTT3_NP '_'' ;_: and_CC Tat_NP HIV3_NP ,_, 5'CCAAGCTTCGAGCTATTCCTTC3_NP '_POS ._SENT Cells_NNS ._SENT |_SYM Human_NP epithelioid_JJ carcinoma_NN HeLa_NP cells_NNS were_VBD maintained_VBN at_IN 37C_JJ in_IN 5_CD %_NN CO2_NP in_IN Dulbecco_NP 's_POS minimal_JJ essential_JJ medium_NN (_( Life_NP Technologies_NP ,_, Cergy_NP Pontoise_NP ,_, France_NP )_) supplemented_VBD with_IN 10_CD %_NN fetal_JJ calf_NN serum_NN (_( Life_NP Technologies_NPS )_) ._SENT Large_JJ T_NN immortalized_VBD goat_NN embryo_NN fibroblasts_NNS (_( TIGEF_NP )_) and_CC goat_NN synovial_JJ membrane_NN (_( GSM_NN )_) cells_NNS were_VBD maintained_VBN in_IN Eagle_NP 's_POS minimal_JJ essential_JJ medium_NN (_( Life_NP Technologies_NP )_) supplemented_VBD with_IN 10_CD %_NN fetal_JJ calf_NN serum_NN ._SENT Transfection_NN of_IN plasmid_NP DNAs_NP and_CC virus_NN production_NN ._SENT |_SYM HeLa_NP cells_NNS or_CC TIGEF_NP were_VBD seeded_VBN into_IN 60-mm-diameter_JJ (_( 2_CD 105_CD cells/plate_NN )_) or_CC 100-mm-diameter_NN (_( 5_CD 105_CD cells/plate_NN )_) tissue_NN culture_NN petri_NNS dishes_NNS (_( Elvetech_NP ,_, Lyon_NP ,_, France_NP )_) and_CC maintained_VBN in_IN culture_NN for_IN 24_CD h_NN before_IN transfection_NN with_IN Effectene_NP (_( Qiagen_NP ,_, Courtaboeuf_NP ,_, France_NP )_) ,_, according_VBG to_TO the_DT manufacturer_NN 's_POS recommendations_NNS ._SENT Briefly_RB ,_, for_IN a_DT 60-mm_JJ dish_NN ,_, 8_CD mul_NN of_IN enhancer_NN was_VBD added_VBN to_TO 1_CD mug_NN of_IN the_DT relevant_JJ plasmid_NP DNA_NP in_IN DNA_NP condensation_NN buffer_NN and_CC incubated_VBN for_IN 3_CD min_NN at_IN room_NN temperature_NN prior_RB to_TO the_DT addition_NN of_IN 10_CD mul_NN of_IN Effectene_NN reagent_NN ._SENT After_IN a_DT further_JJR 10_CD min_NN at_IN room_NN temperature_NN ,_, the_DT mixture_NN was_VBD added_VBN to_TO the_DT culture_NN dish_NN and_CC incubated_VBN for_IN 5_CD h_NN before_IN the_DT medium_NN was_VBD changed_VBN ._SENT For_IN 100-mm_NP dishes_NNS ,_, double_JJ quantities_NNS of_IN DNA_NN and_CC reagents_NNS were_VBD used_VBN ._SENT CAEV-pBSCA_NP virus_NN stock_NN was_VBD generated_VBN by_IN Lipofectamine_NP (_( Life_NP Technologies_NPS )_) transfection_NN of_IN 5_CD mug_NN of_IN plasmid_NP pBSCA_NP DNA_NP into_IN 5_CD 105_CD GSM_NN cells_NNS which_WDT had_VBD been_VBN seeded_VBN into_IN a_DT 25-cm2_JJ tissue_NN culture_NN flask_NN 24_CD h_NN previously_RB ._SENT After_IN 18_CD h_NN and_CC three_CD washes_VBZ with_IN phosphate-buffered_JJ saline_NN (_( PBS_NP )_) ,_, the_DT medium_NN was_VBD replaced_VBN and_CC the_DT virus-containing_JJ supernatant_JJ medium_NN was_VBD collected_VBN at_IN 3_CD ,_, 5_CD ,_, and_CC 7_CD days_NNS posttransfection_NN ._SENT Supernatants_NNS were_VBD stored_VBN at_IN -80C_NN after_IN they_PP were_VBD clarified_VBN through_IN 45-mum-pore-size_JJ membranes_NNS (_( Millipore_NP ,_, St._NP Quentin_NP ,_, France_NP )_) ._SENT MVV_NP strain_NN K1514_NP was_VBD produced_VBN on_IN GSM_NN cells_NNS under_IN standard_JJ conditions_NNS ._SENT Immunoprecipitation_NN assay_NN ._SENT |_SYM Supernatant_NP (_( 1_CD ml_NN )_) was_VBD collected_VBN from_IN 60-mm_JJ culture_NN dishes_VBZ 48_CD h_NN after_IN transfection_NN and_CC immediately_RB mixed_JJ with_IN 100_CD mul_NN of_IN 10x_NP radioimmunoprecipitation_NN assay_NN (_( RIPA_NP )_) buffer_NN (_( 0.5_CD M_NP Tris_NP [_SYM pH_NN 7.5_CD ]_SYM ,_, 0.5_CD M_NP NaCl_NP ,_, 5_CD %_NN deoxycholic_JJ acid_NN ,_, 2_CD %_NN sodium_NN dodecyl_JJ sulfate_NN [_SYM SDS_NP ]_SYM ,_, 0.1_CD M_NP EDTA_NP )_) ._SENT The_DT cell_NN layer_NN was_VBD then_RB scraped_VBN into_IN 1_CD ml_NN of_IN 1x_NP RIPA_NP buffer_NN ,_, transferred_VBN into_IN a_DT 1.5-ml_JJ Eppendorf_NP tube_NN ,_, and_CC clarified_VBN by_IN centrifugation_NN for_IN 10_CD min_NN at_IN 1,300_CD x_SYM g._FW Specific_JJ antigens_NNS were_VBD sought_VBN by_IN adding_VBG 1_CD mul_NN of_IN anti-FLAG_NN antibody_NN (_( Bio-Rad_NP ,_, Marnes-la-Coquette_NP ,_, France_NP )_) or_CC 5_CD mul_NN of_IN anti-SV40_JJ large_JJ T_NN antibody_NN (_( Santa_NP Cruz_NP Biotechnology_NP ,_, Santa_NP Cruz_NP ,_, Calif._NP )_) in_IN 20_CD mul_NN of_IN 1x_NP RIPA_NP buffer_NN to_TO 50_CD mul_NN of_IN a_DT 6_CD %_NN suspension_NN of_IN protein_NN A-Sepharose_NP (_( Sigma_NP ,_, La_NP Verpillere_NP ,_, France_NP )_) ;_: this_DT mixture_NN was_VBD then_RB added_VBN to_TO the_DT cell_NN supernatant_JJ or_CC lysate_JJ preparations_NNS in_IN a_DT fresh_JJ Eppendorf_NP tube_NN ,_, which_WDT was_VBD stored_VBN overnight_RB at_IN 4C_JJ on_IN a_DT rocker_NN ._SENT The_DT Sepharose_NP beads_NNS were_VBD then_RB recovered_VBN by_IN centrifugation_NN at_IN 500_CD x_NN g_NN for_IN 2_CD min_NN and_CC washed_VBD five_CD times_NNS in_IN 1x_NP RIPA_NP buffer_NN ;_: the_DT captured_VBN antigens_NNS were_VBD released_VBN for_IN immunoblot_NN analysis_NN by_IN resuspension_NN in_IN 50_CD mul_NN of_IN 2x_JJ reducing_VBG buffer_NN (_( 80_CD mM_NP Tris_NP [_SYM pH_NN 6.8_CD ]_SYM ,_, 12_CD %_NN glycerol_NN ,_, 2_CD %_NN SDS_NP ,_, 2_CD %_NN beta-mercaptoethanol_NN ,_, bromophenol_NN blue_NN )_) ._SENT Preparation_NN of_IN virions_NNS and_CC cell_NN lysates_NNS ._SENT |_SYM To_TO test_VB whether_IN tagged_VBN SRLV_NP Tat_NP proteins_NNS could_MD be_VB incorporated_VBN into_IN virions_NNS ,_, TIGEF_NP in_IN 100-mm_NP dishes_NNS were_VBD first_RB infected_VBN with_IN either_DT CAEV_NP or_CC MVV_NP (_( multiplicity_NN of_IN infection_NN [_SYM MOI_NP ]_SYM ,_, 1_CD )_) for_IN 2_CD h_NN and_CC then_RB cultured_VBN in_IN fresh_JJ medium_NN for_IN 24_CD h._NNS The_DT TIGEF_NN were_VBD then_RB transfected_VBN with_IN the_DT relevant_JJ plasmids_NNS encoding_VBG FLAG-Tat-tagged_JJ proteins_NNS as_RB described_VBD above_IN ,_, and_CC the_DT culture_NN supernatants_NNS were_VBD collected_VBN 72_CD h_NN later_RBR ._SENT After_IN clarification_NN at_IN 1,300_CD x_NN g_NN for_IN 10_CD min_NN ,_, virions_NNS were_VBD pelleted_VBN from_IN the_DT supernatants_NNS by_IN centrifugation_NN at_IN 100,000_CD x_NN g_NN for_IN 45_CD min_NN at_IN 4C_JJ and_CC then_RB recovered_VBD in_IN 45_CD mul_NN of_IN lysis_NN buffer_NN (_( 10_CD mM_NP Tris_NP [_SYM pH_NN 7.5_CD ]_SYM ,_, 0.15_CD M_NP NaCl_NP ,_, 2_CD mM_NP EDTA_NP ,_, 0.5_CD %_NN Nonidet_NP P-40_NP )_) ._SENT The_DT cell_NN layers_NNS were_VBD washed_VBN twice_RB with_IN PBS_NP and_CC disrupted_VBN with_IN trypsin_NN ._SENT The_DT cells_NNS were_VBD recovered_VBN by_IN centrifugation_NN at_IN 500_CD x_NN g_NN for_IN 5_CD min_NN ,_, resuspended_VBN in_IN 100_CD mul_NN of_IN cold_JJ lysis_NN buffer_NN ,_, and_CC maintained_VBD on_IN ice_NN for_IN 4_CD min_NN before_IN clarification_NN in_IN a_DT microcentrifuge_NN for_IN 5_CD min_NN ._SENT The_DT cell_NN lysates_NNS and_CC virion_NN preparations_NNS were_VBD stored_VBN at_IN -80C_NN until_IN used_VBN ._SENT For_IN density_NN gradient_JJ analysis_NN ,_, six_CD culture_NN dishes_NNS (_( diameter_NN ,_, 100_CD mm_NN )_) of_IN TIGEF_NP were_VBD infected_VBN and_CC then_RB transfected_JJ as_IN described_VBN above_IN ._SENT At_IN 72_CD h_NN posttransfection_NN ,_, the_DT supernatants_NNS were_VBD pooled_VBN and_CC the_DT virions_NNS were_VBD pelleted_VBN by_IN centrifugation_NN at_IN 100,000_CD x_NN g_NN for_IN 45_CD min_NN ._SENT The_DT pellets_NNS were_VBD resuspended_VBN in_IN 500_CD mul_NN of_IN 10_CD mM_NP Tris_NP (_( pH_NN 7.5)-100_NP mM_NP NaCl-1_NP mM_NP EDTA_NP and_CC layered_VBN onto_IN an_DT 11-ml_JJ linear_JJ sucrose_NN gradient_NN (_( 20_CD to_TO 60_CD %_NN [_SYM wt/vol_NN ]_SYM sucrose_NN in_IN 10_CD mM_NP Tris_NP [_SYM pH_NN 7.5]-100_JJ mM_NP NaCl-1_NP mM_NP EDTA_NP )_) ._SENT The_DT gradient_NN was_VBD centrifuged_VBN for_IN 16_CD h_NN at_IN 100,000_CD x_NN g_NN at_IN 10C_NP ,_, and_CC 12_CD fractions_NNS (_( 0.9_CD ml_NN )_) were_VBD collected_VBN from_IN the_DT top_NN of_IN the_DT tube_NN ._SENT Materials_NNS contained_VBD in_IN each_DT fraction_NN were_VBD pelleted_VBN and_CC dissolved_VBN in_IN 30_CD mul_NN of_IN lysis_NN buffer_NN and_CC then_RB subjected_VBN to_TO immunoblot_NN analysis_NN ._SENT Immunoblot_NN analysis_NN ._SENT |_SYM Proteins_NPS from_IN lysates_NNS (_( 10_CD mul_NN )_) or_CC supernatants_NNS (_( 20_CD mul_NN )_) in_IN sample_NN reducing_VBG buffer_NN were_VBD separated_VBN on_IN 16.5_CD %_NN polyacrylamide_NN gels_NNS in_IN the_DT presence_NN of_IN SDS_NP ._SENT The_DT proteins_NNS were_VBD transferred_VBN from_IN the_DT gel_NN to_TO nitrocellulose_NN transfer_NN membranes_NNS (_( Schleicher_NP &_CC Schuell_NP ,_, Ecquevilly_NP ,_, France_NP )_) ,_, which_WDT were_VBD probed_VBN with_IN monoclonal_NN antibodies_NNS directed_VBN against_IN the_DT FLAG_NP epitope_NN (_( diluted_VBN 10,000_CD times_NNS ;_: Bio-Rad_NP )_) ,_, SV40_NP large_JJ T_NN antigen_NN (_( diluted_VBN 1,000_CD times_NNS ;_: Santa_NP Cruz_NP Biotechnology_NP )_) ,_, or_CC CAEV_NP capsid_NN protein_NN (_( CAEP8B1_JJ monoclonal_NN antibody_NN ,_, diluted_VBD 1,000_CD times_NNS ;_: VMRD_NP Inc._NP ,_, Pullman_NP ,_, Wash._NP )_) Bound_NP antibodies_NNS were_VBD detected_VBN by_IN incubation_NN with_IN horseradish_NN peroxidase-conjugated_JJ goat_NN anti-mouse_NN immunoglobulin_NN G_NP (_( diluted_VBN 3,000_CD times_NNS ;_: Bio-Rad_NP )_) and_CC visualized_VBN by_IN enhanced_JJ chemiluminescence_NN (_( ECL_NN kit_NN ;_: Amersham_NP ,_, Saclay_NP ,_, France_NP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS instructions_NNS ._SENT Flow_NN cytometry_NN analysis_NN of_IN G2_NP arrest_NN of_IN cell_NN cycle_NN ._SENT |_SYM The_DT cell_NN cycle_NN was_VBD studied_VBN quantitatively_RB by_IN flow_NN cytometric_JJ determination_NN of_IN the_DT nuclear_JJ DNA_NN content_NN after_IN cells_NNS were_VBD stained_VBN with_IN propidium_NN iodide_NN (_( Sigma_NP )_) as_IN previously_RB described_VBN ._SENT Briefly_RB ,_, 5_CD 105_CD transfected_JJ cells_NNS were_VBD harvested_VBN following_VBG dissociation_NN with_IN trypsin_NN ;_: they_PP were_VBD then_RB rinsed_VBN and_CC resuspended_VBN in_IN 1_CD ml_NN of_IN PBS_NP ._SENT Cell_NN suspensions_NNS were_VBD then_RB fixed_VBN by_IN the_DT addition_NN of_IN 500_CD mul_NN of_IN 1_CD %_NN paraformaldehyde_NN and_CC a_DT 30-min_JJ incubation_NN in_IN ice_NN ._SENT The_DT fixed_VBN cells_NNS were_VBD rinsed_VBN once_RB with_IN PBS_NP ,_, incubated_VBN for_IN 30_CD min_NN at_IN room_NN temperature_NN in_IN a_DT solution_NN containing_VBG RNase_NP A_NP (_( 10_CD mg/ml_NN )_) ,_, and_CC then_RB stained_VBN by_IN the_DT addition_NN of_IN 2_CD mul_NN of_IN 10-mg/ml_JJ propidium_NN iodide_NN solution_NN ._SENT The_DT DNA_NP content_NN was_VBD finally_RB analyzed_VBN for_IN more_JJR than_IN 10,000_CD events_NNS by_IN FACScan_NP flow_NN cytometry_NN (_( Becton_NP Dickinson_NP ,_, Le_NP Pont_NP de_NP Claix_NP ,_, France_NP )_) ._SENT The_DT cell_NN cycle_NN distribution_NN of_IN fluorescent_JJ transfected_JJ cells_NNS was_VBD analyzed_VBN with_IN Cell_NP Quest_NP software_NN ._SENT Background_NN levels_NNS of_IN fluorescence_NN were_VBD determined_VBN by_IN using_VBG mock-transfected_JJ cells_NNS ._SENT Subcellular_JJ localization_NN of_IN MVV_NP Tat_NP protein_NN ._SENT |_SYM We_PP evaluated_VBD the_DT intracellular_JJ localization_NN of_IN an_DT SRLV_NP Tat_NP protein_NN by_IN comparing_VBG the_DT distribution_NN of_IN fluorescence_NN in_IN TIGEF_NP transfected_VBD with_IN a_DT plasmid_NP (_( pGFP-Tat_NN )_) expressing_VBG a_DT GFP-MVV_NP Tat_NP fusion_NN protein_NN with_IN that_DT in_IN cells_NNS transfected_VBN by_IN the_DT pGFP_NN plasmid_NN ,_, which_WDT expresses_VBZ only_RB the_DT fluorescent_JJ marker_NN ._SENT GFP_NP was_VBD distributed_VBN throughout_IN the_DT cytoplasm_NN and_CC nucleus_NN of_IN the_DT transfected_JJ cells_NNS ,_, as_RB observed_VBN by_IN fluorescence_NN microscopy_NN at_IN 48_CD h_NN posttransfection_NN ,_, whereas_IN the_DT GFP-Tat_NP fusion_NN protein_NN was_VBD essentially_RB present_JJ in_IN the_DT nucleus_NN ._SENT To_TO establish_VB which_WDT portion_NN of_IN the_DT MVV_NP Tat_NP protein_NN was_VBD responsible_JJ for_IN this_DT localization_NN ,_, we_PP constructed_VBD two_CD further_JJR plasmids_NNS expressing_VBG either_CC the_DT N-terminal_JJ (_( activator_NN )_) portion_NN or_CC the_DT leucine-rich_JJ C-terminal_JJ portion_NN of_IN the_DT protein_NN as_IN fusions_NNS with_IN GFP_NP ._SENT TIGEF_NP transfected_VBD with_IN the_DT construct_NN expressing_VBG the_DT N-terminal_JJ portion_NN of_IN MVV_NP Tat_NP and_CC examined_VBD 48_CD h_NN later_RBR showed_VBD a_DT distribution_NN of_IN fluorescence_NN throughout_IN the_DT whole_JJ cell_NN ,_, like_IN the_DT distribution_NN for_IN GFP_NP alone_RB ,_, whereas_IN the_DT cells_NNS transfected_VBN with_IN the_DT construct_NN expressing_VBG the_DT C-terminal_JJ portion_NN of_IN MVV_NP Tat_NP showed_VBD a_DT nuclear_JJ localization_NN of_IN fluorescence_NN ,_, like_IN the_DT distribution_NN for_IN the_DT intact_JJ Tat_NP protein_NN ._SENT MVV_NP Tat_NP protein_NN is_VBZ not_RB released_VBN from_IN transfected_JJ cells_NNS ._SENT |_SYM It_PP has_VBZ been_VBN clearly_RB demonstrated_VBN that_IN the_DT HIV-1_NP Tat_NP protein_NN is_VBZ secreted_VBN into_IN the_DT culture_NN medium_NN by_IN infected_JJ ,_, or_CC transfected_JJ ,_, cells_NNS ,_, so_RB we_PP investigated_VBD whether_IN an_DT SRLV_NP Tat_NP protein_NN was_VBD also_RB present_JJ in_IN the_DT supernatant_JJ medium_NN of_IN our_PP$ transfected_JJ cells_NNS ._SENT To_TO facilitate_VB detection_NN of_IN the_DT Tat_NP proteins_NNS ,_, they_PP were_VBD expressed_VBN as_IN fusion_NN proteins_NNS with_IN the_DT FLAG_NP epitope_NN by_IN the_DT plasmids_NNS pTat-Flag-MVV_NP and_CC pTat-Flag-HIV_NP ._SENT At_IN 48_CD h_NN after_IN transfection_NN of_IN HeLa_NP cells_NNS ,_, the_DT supernatant_JJ media_NNS were_VBD collected_VBN and_CC analyzed_VBN by_IN immunoblot_NN analysis_NN following_VBG specific_JJ immunoprecipitation_NN with_IN the_DT antibody_NN to_TO the_DT FLAG_NP epitope_NN ._SENT The_DT cell_NN monolayer_NN was_VBD also_RB lysed_VBN and_CC subjected_VBN to_TO the_DT same_JJ analysis_NN ._SENT As_IN expected_VBN ,_, the_DT HIV-1_NP Tat_NP protein_NN was_VBD easily_RB detectable_JJ in_IN both_CC the_DT cell_NN lysate_NN and_CC the_DT supernatant_JJ medium_NN ,_, but_CC MVV_NP Tat_NP was_VBD absent_JJ from_IN the_DT supernatant_JJ medium_NN ,_, although_IN clearly_RB present_JJ in_IN the_DT cell_NN lysate_NN ._SENT Because_IN the_DT secretion_NN of_IN the_DT Tat_NP protein_NN into_IN the_DT supernatant_JJ might_MD be_VB a_DT property_NN that_WDT is_VBZ characteristic_JJ of_IN natural_JJ host_NN cells_NNS for_IN the_DT virus_NN ,_, we_PP repeated_VBD the_DT experiment_NN using_VBG caprine_JJ TIGEF_NN as_IN hosts_NNS for_IN the_DT two_CD plasmids_NNS ._SENT Again_RB ,_, the_DT HIV-1_NP Tat_NP protein_NN was_VBD clearly_RB present_JJ in_IN the_DT supernatant_JJ ,_, although_IN in_IN a_DT smaller_JJR quantity_NN than_IN when_WRB it_PP was_VBD expressed_VBN in_IN HeLa_NP cells_NNS ,_, and_CC the_DT MVV_NP Tat_NP protein_NN was_VBD seen_VBN only_RB in_IN the_DT cell_NN lysate_NN ._SENT TIGEF_NP constitutively_RB express_VB the_DT SV40_NP large_JJ T_NN antigen_NN ,_, which_WDT was_VBD used_VBN for_IN their_PP$ immortalization_NN ,_, so_RB we_PP probed_VBD the_DT samples_NNS with_IN the_DT antibody_NN to_TO SV40_NP large_JJ T_NN as_IN an_DT internal_JJ control_NN ._SENT The_DT antigen_NN was_VBD clearly_RB present_JJ in_IN the_DT cell_NN lysates_NNS and_CC absent_JJ from_IN either_DT supernatant_JJ ,_, suggesting_VBG that_IN the_DT secretion_NN of_IN HIV-1_NP Tat_NP into_IN the_DT medium_NN was_VBD a_DT specific_JJ event_NN and_CC not_RB simply_RB due_JJ to_TO cellular_JJ leakage_NN (_( data_NNS not_RB shown_VBN )_) ._SENT In_IN summary_NN ,_, MVV_NP Tat_NP ,_, unlike_IN HIV-1_NP Tat_NP ,_, is_VBZ not_RB actively_RB secreted_VBN into_IN the_DT culture_NN medium_NN from_IN transfected_JJ human_JJ or_CC caprine_JJ cell_NN cultures_NNS ._SENT Incorporation_NN of_IN tagged_VBN Tat_NP into_IN virions_NNS ._SENT |_SYM We_PP next_RB tested_VBD whether_IN SRLV_NP Tat_NP proteins_NNS ,_, although_IN not_RB released_VBN free_JJ into_IN the_DT supernatant_JJ of_IN transfected_JJ cells_NNS ,_, were_VBD incorporated_VBN in_IN the_DT virions_NNS on_IN productive_JJ infection_NN ._SENT TIGEF_NP were_VBD infected_VBN at_IN an_DT MOI_NP of_IN 1_CD with_IN either_DT MVV_NP or_CC CAEV_NP and_CC then_RB transfected_VBD 24_CD h_NN later_RBR with_IN pTat-Flag-MVV_NP or_CC the_DT equivalent_JJ pTat-Flag-CO_NN plasmids_NNS ,_, respectively_RB ._SENT Supernatants_NNS and_CC cell_NN lysates_NNS were_VBD collected_VBN 72_CD h_NN later_RBR and_CC analyzed_VBD by_IN immunoblotting_NN with_IN the_DT anti-FLAG_NN monoclonal_NN antibody_NN ._SENT Control_NN samples_NNS were_VBD mock_JJ infected_JJ and_CC then_RB transfected_JJ similarly_RB ._SENT As_IN shown_VBN in_IN Fig._NN and_CC B_NP ,_, cell_NN lysates_NNS from_IN cells_NNS transfected_VBN with_IN MVV_NP or_CC CAEV_NP Tat-Flag_NP plasmids_NNS contained_VBD an_DT abundant_JJ 11-kDa_NP band_NN recognized_VBN by_IN the_DT anti-FLAG_NN antibody_NN ,_, whether_IN they_PP were_VBD infected_VBN with_IN a_DT replicative_JJ virus_NN or_CC not_RB ._SENT In_IN contrast_NN ,_, an_DT 11-kDa_NP band_NN was_VBD present_JJ only_RB in_IN the_DT supernatants_NNS of_IN infected_JJ cells_NNS and_CC never_RB in_IN those_DT of_IN the_DT noninfected_JJ controls_NNS ._SENT Since_IN the_DT result_NN described_VBN above_IN suggested_VBD that_IN SRLV_NP Tat_NP proteins_NNS might_MD be_VB incorporated_VBN into_IN budding_JJ virions_NNS ,_, we_PP analyzed_VBD the_DT supernatant_JJ from_IN CAEV-infected_JJ and_CC transfected_JJ cells_NNS by_IN density_NN gradient_JJ ultracentrifugation_NN ._SENT Cells_NNS were_VBD infected_VBN and_CC transfected_VBN as_IN described_VBN above_IN ,_, the_DT supernatant_JJ medium_NN was_VBD subjected_VBN to_TO high-speed_JJ centrifugation_NN ,_, and_CC the_DT resuspended_JJ pellet_NN was_VBD placed_VBN on_IN the_DT top_NN of_IN a_DT linear_JJ sucrose_NN gradient_NN as_IN described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT After_IN ultracentrifugation_NN ,_, the_DT gradient_NN was_VBD divided_VBN into_IN 12_CD fractions_NNS ,_, and_CC these_DT were_VBD analyzed_VBN for_IN the_DT CAEV_NP Tat_NP fusion_NN protein_NN with_IN the_DT anti-FLAG_NN antibody_NN and_CC for_IN the_DT major_JJ CAEV_NP capsid_NN antigen_NN by_IN using_VBG an_DT anti-CAEV_NP p25_NP Gag_NP antibody_NN ._SENT Proteins_NNS were_VBD separated_VBN by_IN SDS-polyacrylamide_NP gel_NN electrophoresis_NN and_CC analyzed_VBD by_IN immunoblotting_NN with_IN the_DT antibodies_NNS mentioned_VBN above_IN ,_, and_CC the_DT Tat-FLAG_NP fusions_NNS always_RB colocalized_VBN with_IN the_DT CAEV_NP capsid_NN proteins_NNS ._SENT This_DT strongly_RB suggests_VBZ that_IN the_DT SRLV_NP Tat_NP proteins_NNS are_VBP incorporated_VBN into_IN the_DT viral_JJ particle_NN ._SENT Expression_NN of_IN Tat_NP increases_VBZ the_DT proportion_NN of_IN cells_NNS arrested_VBN in_IN the_DT G2_NP phase_NN of_IN the_DT cell_NN cycle_NN ._SENT |_SYM The_DT possible_JJ effect_NN of_IN the_DT SRLV_NP Tat_NP proteins_NNS on_IN the_DT cell_NN cycle_NN of_IN the_DT infected_JJ cells_NNS was_VBD investigated_VBN by_IN using_VBG TIGEF_NP transiently_RB transfected_VBD with_IN an_DT MVV_NP Tat-GFP_NP fusion_NN protein_NN and_CC then_RB fixed_VBN and_CC stained_VBN with_IN propodium_NN iodide_NN ._SENT This_DT procedure_NN allowed_VBD simultaneous_JJ evaluation_NN of_IN the_DT expression_NN of_IN the_DT Tat_NP fusion_NN and_CC of_IN the_DT quantity_NN of_IN cellular_JJ DNA_NN ._SENT Control_NN cells_NNS were_VBD transfected_VBN with_IN GFP_NP alone_RB ._SENT DNA_NP profiles_NNS were_VBD determined_VBN at_IN 72_CD and_CC 120_CD h_NN posttransfection_NN ._SENT At_IN 72_CD h_NN ,_, for_IN cells_NNS transfected_VBN with_IN GFP_NP alone_RB ,_, 46_CD %_NN of_IN the_DT transfected_JJ cells_NNS were_VBD in_IN the_DT G1/S_NP phase_NN and_CC 35_CD %_NN were_VBD in_IN the_DT G2/M_NP phase_NN of_IN their_PP$ cycles_NNS ;_: for_IN Tat-transfected_JJ cells_NNS ,_, only_RB 24_CD %_NN were_VBD in_IN the_DT G1/S_NP phase_NN compared_VBN to_TO 51_CD %_NN in_IN G2/M_NP at_IN the_DT same_JJ time_NN ._SENT Assuming_VBG that_IN the_DT time_NN spent_VBN in_IN M_NP and_CC S_NP is_VBZ unchanged_JJ ,_, this_DT represents_VBZ an_DT increase_NN of_IN 2.8-fold_NN in_IN the_DT ratio_NN of_IN cells_NNS in_IN G2_NP to_TO G1_NP in_IN Tat-transfected_JJ cells_NNS ._SENT At_IN 120_CD h_NN posttransfection_NN ,_, the_DT effect_NN was_VBD less_RBR pronounced_VBN ,_, but_CC the_DT Tat-transfected_JJ cells_NNS still_RB showed_VBD a_DT 1.5-fold_NN increase_NN in_IN the_DT G2/G1_JJ ratio_NN ._SENT It_PP has_VBZ recently_RB been_VBN shown_VBN that_IN the_DT proteins_NNS translated_VBN from_IN the_DT open_JJ reading_NN frames_NNS identified_VBN as_IN tat_NN in_IN the_DT SRLV_NP do_VBP not_RB function_VB primarily_RB as_RB up_IN regulators_NNS of_IN transcription_NN from_IN the_DT viral_JJ LTR_NP ,_, as_RB do_VBP the_DT Tat_NP peptides_NNS of_IN the_DT primate_NN lentiviruses_NNS ._SENT In_IN the_DT present_JJ study_NN we_PP pursued_VBD a_DT comparison_NN of_IN the_DT SRLV_NP Tat_NP proteins_NNS with_IN the_DT different_JJ primate_NN lentivirus_NN accessory_JJ and_CC regulatory_JJ proteins_NNS ._SENT We_PP used_VBD vectors_NNS expressing_VBG SRLV_NP Tat_NP proteins_NNS fused_VBD to_TO identifiable_JJ markers_NNS to_TO examine_VB the_DT intracellular_JJ distribution_NN of_IN the_DT protein_NN ,_, its_PP$ secretion_NN into_IN the_DT supernatant_JJ medium_NN ,_, and_CC its_PP$ possible_JJ incorporation_NN into_IN released_VBN virions_NNS ._SENT Finally_RB ,_, we_PP evaluated_VBD the_DT capacity_NN of_IN an_DT SRLV_NP Tat_NP peptide_NN to_TO mediate_VB an_DT important_JJ function_NN of_IN an_DT HIV-1_JJ accessory_JJ protein_NN which_WDT is_VBZ the_DT specific_JJ arrest_NN in_IN the_DT G2_NP phase_NN of_IN the_DT cell_NN cycle_NN ._SENT Cells_NNS transfected_VBN with_IN a_DT plasmid_NN encoding_VBG native_JJ MVV_NP Tat_NP fused_VBD to_TO GFP_NP showed_VBD a_DT clear_JJ nuclear_JJ fluorescence_NN ,_, with_IN occasional_JJ ,_, possibly_RB perinuclear_JJ ,_, patches_NNS ._SENT We_PP did_VBD not_RB observe_VB the_DT nucleolar_JJ concentration_NN typical_JJ of_IN HIV-1_NP Tat_NP ._SENT A_DT similar_JJ pattern_NN of_IN expression_NN is_VBZ obtained_VBN when_WRB GFP_NP is_VBZ fused_VBN to_TO the_DT C-terminal_NP ,_, leucine-_NN and_CC cysteine-enriched_JJ portion_NN of_IN the_DT MVV_NP Tat_NP protein_NN ,_, but_CC the_DT N-terminal_JJ portion_NN (_( the_DT so-called_JJ activator_NN domain_NN )_) does_VBZ not_RB direct_VB a_DT nuclear_JJ concentration_NN ._SENT The_DT C-terminal_JJ portion_NN of_IN MVV_NP Tat_NP begins_VBZ within_IN the_DT leucine-rich_NN conserved_VBD region_NN and_CC extends_VBZ to_TO the_DT natural_JJ terminator_NN following_VBG another_DT well-conserved_JJ cysteine-rich_JJ domain_NN ._SENT The_DT intermediate_JJ region_NN ,_, although_IN globally_RB not_RB well_RB conserved_VBN between_IN different_JJ viral_JJ isolates_NNS ,_, always_RB contains_VBZ many_JJ basic_JJ amino_NN acids_NNS ,_, often_RB in_IN individually_RB conserved_VBN positions_NNS ,_, which_WDT may_MD constitute_VB a_DT nuclear_JJ localization_NN signal_NN ._SENT Studies_NNS involving_VBG site-directed_JJ mutagenesis_NN of_IN these_DT amino_NN acids_NNS in_IN the_DT present_JJ construct_NN may_MD clarify_VB their_PP$ role_NN ._SENT Using_VBG the_DT FLAG_NP epitope_NN fused_VBD to_TO the_DT SRLV_NP Tat_NP proteins_VBZ ,_, we_PP showed_VBD that_IN these_DT proteins_NNS are_VBP not_RB secreted_VBN into_IN the_DT medium_NN from_IN transfected_JJ cells_NNS ,_, unlike_IN tagged_VBN HIV-1_NP Tat_NP ,_, which_WDT is_VBZ secreted_VBN from_IN the_DT same_JJ cells_NNS under_IN the_DT same_JJ conditions_NNS ._SENT In_IN natural_JJ infections_NNS ,_, HIV-1_NP Tat_NP excreted_VBD from_IN an_DT infected_JJ cell_NN is_VBZ believed_VBN to_TO enter_VB neighboring_JJ cells_NNS and_CC to_TO contribute_VB to_TO the_DT development_NN of_IN pathology_NN ._SENT The_DT amino_NN acid_NN sequence_NN of_IN HIV-1_NP Tat_NP contains_VBZ no_DT identifiable_JJ secretion_NN signal_NN ,_, and_CC such_JJ leaderless_JJ secreted_VBN proteins_NNS are_VBP believed_VBN to_TO be_VB externalized_VBN through_IN the_DT endoplasmic_JJ reticulum_NN and_CC Golgi_NP apparatus_NN by_IN a_DT nonclassical_JJ pathway_NN which_WDT is_VBZ still_RB poorly_RB understood_VBN ._SENT We_PP show_VBP in_IN this_DT study_NN that_IN FLAG-tagged_NP HIV-1_NP Tat_NP is_VBZ secreted_VBN from_IN transfected_JJ caprine_JJ cells_NNS (_( TIGEF_NP )_) ,_, although_IN less_RBR efficiently_RB than_IN from_IN human_JJ (_( HeLa_NP )_) cells_NNS ._SENT This_DT suggests_VBZ that_IN the_DT mechanism_NN for_IN export_NN of_IN leaderless_JJ secreted_VBN proteins_NNS is_VBZ conserved_VBN in_IN mammals_NNS but_CC that_IN HIV-1_NP Tat_NP is_VBZ specifically_RB better_RBR adapted_VBN to_TO the_DT human_JJ mechanism_NN ._SENT The_DT absence_NN of_IN MVV_NP Tat_NP from_IN the_DT supernatants_NNS of_IN either_DT human_JJ or_CC caprine_JJ cells_NNS suggests_VBZ that_IN it_PP does_VBZ not_RB employ_VB this_DT cellular_JJ mechanism_NN ._SENT The_DT findings_NNS described_VBD above_RB indicate_VB important_JJ functional_JJ differences_NNS between_IN HIV-1_NP Tat_NP and_CC the_DT SRLV_NP Tat_NP proteins_NNS ,_, which_WDT are_VBP emphasized_VBN by_IN the_DT finding_NN that_IN the_DT latter_NN are_VBP exported_VBN from_IN actively_RB infected_VBN cells_NNS in_IN association_NN with_IN the_DT viral_JJ particles_NNS ._SENT A_DT comparison_NN with_IN other_JJ regulatory_JJ and_CC accessory_JJ proteins_NNS of_IN the_DT primate_NN lentiviruses_NNS showed_VBD a_DT considerable_JJ similarity_NN to_TO the_DT Vpr_NP accessory_JJ protein_NN ._SENT This_DT is_VBZ a_DT small_JJ 96-amino-acid_NN (_( 14-kDa_NP )_) protein_NN which_WDT is_VBZ expressed_VBN in_IN the_DT nucleus_NN and_CC is_VBZ exported_VBN in_IN the_DT viral_JJ particles_NNS budding_VBG from_IN infected_JJ cells_NNS ._SENT FLAG_NN labeling_VBG of_IN HIV-1_NP Vpr_NP did_VBD not_RB alter_VB its_PP$ distribution_NN in_IN infected_JJ cells_NNS or_CC viral_JJ particles_NNS ._SENT Characteristic_JJ functions_NNS of_IN HIV-1_NP Vpr_NP include_VBP arrest_NN of_IN infected_JJ cells_NNS in_IN the_DT G2/M_NP phase_NN of_IN their_PP$ cycle_NN by_IN inhibition_NN of_IN p34cdc2_JJ activity_NN ,_, participation_NN in_IN nuclear_JJ import_NN of_IN the_DT viral_JJ preintegration_NN complex_NN in_IN nondividing_JJ cells_NNS ,_, and_CC a_DT weak_JJ (_( two-_NN to_TO sevenfold_JJ )_) trans-activation_NN of_IN the_DT viral_JJ LTR_NP ._SENT Alignment_NN of_IN the_DT primary_JJ amino_NN acid_NN sequences_NNS of_IN the_DT SRLV_NP Tat_NP proteins_NNS and_CC HIV-1_NP Vpr_NP protein_NN showed_VBD that_IN both_DT sequences_NNS contain_VBP an_DT acidic_JJ N-terminal_JJ domain_NN ,_, a_DT central_JJ leucine-rich_JJ domain_NN ,_, and_CC an_DT arginine-rich_JJ C-terminal_JJ portion_NN ._SENT The_DT C-terminal_JJ portion_NN of_IN the_DT SRLV_NP Tat_NP is_VBZ usually_RB described_VBN as_IN cysteine_NN rich_JJ ;_: however_RB ,_, it_PP can_MD be_VB seen_VBN that_IN this_DT sequence_NN is_VBZ also_RB relatively_RB rich_JJ in_IN arginine_NN residues_NNS ._SENT Thus_RB ,_, the_DT primary_JJ structures_NNS of_IN SRLV_NP Tat_NP and_CC HIV-1_NP Vpr_NP proteins_NNS are_VBP very_RB similar_JJ ,_, and_CC the_DT same_JJ main_JJ domains_NNS are_VBP conserved_VBN ._SENT In_IN contrast_NN ,_, a_DT corresponding_JJ examination_NN of_IN the_DT primary_JJ structure_NN of_IN HIV-1_NP Tat_NP protein_NN revealed_VBD no_DT noteworthy_JJ similarity_NN with_IN the_DT structures_NNS of_IN either_DT SRLV_NP Tat_NP or_CC HIV-1_NP Vpr_NP ._SENT This_DT resemblance_NN of_IN the_DT SRLV_NP Tat_NP proteins_NNS to_TO HIV-1_NP Vpr_NP is_VBZ reinforced_VBN by_IN our_PP$ finding_NN that_IN cells_NNS transfected_VBN with_IN a_DT plasmid_NN expressing_VBG an_DT MVV_NP Tat-GFP_NP fusion_NN protein_NN accumulate_VBP in_IN the_DT G2/M_NP phase_NN of_IN the_DT cell_NN cycle_NN ,_, with_IN a_DT 2.8-fold_JJ increase_NN in_IN cells_NNS in_IN G2/M_NP compared_VBN to_TO those_DT in_IN G1/S_NP at_IN 72_CD h_NN posttransfection_NN ._SENT The_DT effect_NN persisted_VBD at_IN lower_JJR levels_NNS until_IN at_IN least_JJS 120_CD h_NN posttransfection_NN ._SENT This_DT result_NN indicates_VBZ that_IN MVV_NP Tat_NP ,_, like_IN HIV-1_NP Vpr_NP ,_, induces_VBZ specific_JJ arrest_NN in_IN the_DT G2_NP phase_NN of_IN the_DT cell_NN cycle_NN ._SENT In_IN conclusion_NN ,_, the_DT different_JJ properties_NNS of_IN the_DT SRLV_NP Tat_NP proteins_NNS ,_, including_VBG primary_JJ amino_NN acid_NN sequence_NN ,_, cellular_JJ and_CC virion_NN localization_NN ,_, absence_NN of_IN strong_JJ transactivation_NN of_IN the_DT viral_JJ LTR_NP ,_, and_CC cellular_JJ arrest_NN in_IN the_DT G2_NP phase_NN of_IN the_DT cycle_NN ,_, lead_VBP to_TO the_DT conclusion_NN that_IN this_DT protein_NN is_VBZ better_RBR considered_VBN an_DT accessory_JJ protein_NN similar_JJ to_TO the_DT Vpr_NP protein_NN of_IN the_DT primate_NN lentiviruses_NNS and_CC that_IN the_DT SRLV_NP do_VBP not_RB encode_VB a_DT veritable_JJ Tat_NP protein_NN ._SENT Localization_NN of_IN wild-type_NN and_CC mutant_JJ MVV_NP Tat-GFP_NP fusion_NN proteins_NNS ._SENT Localization_NN of_IN wild-type_NN and_CC mutant_JJ MVV_NP Tat-GFP_NP fusion_NN proteins_NNS ._SENT The_DT TIGEF_NP cell_NN line_NN was_VBD transfected_VBN with_IN pGFP_NN (_( A_NP )_) ,_, pGFP-Tat_NP (_( B_NP )_) ,_, pGFP-5_NP '_POS (_( C_NP )_) ,_, and_CC pGFP-3_NN '_'' (_( D_NP )_) plasmid_NN constructs_NNS ;_: 48_CD h_NN posttransfection_NN ,_, the_DT cells_NNS were_VBD observed_VBN by_IN fluorescence_NN microscopy_NN ._SENT Magnification_NN ,_, x400_NN ._SENT Release_NN of_IN the_DT Tat_NP protein_NN in_IN the_DT supernatant_JJ of_IN Tat-expressing_NP cells_NNS ._SENT Release_NN of_IN the_DT Tat_NP protein_NN in_IN the_DT supernatant_JJ of_IN Tat-expressing_NP cells_NNS ._SENT The_DT human_JJ HeLa_NP (_( A_NP )_) or_CC goat_NN TIGEF_NP (_( B_NP )_) cell_NN lines_NNS were_VBD transfected_VBN with_IN the_DT pTat-Flag-MVV_NP and_CC pTat-Flag-HIV_NP plasmid_NP constructs_VBZ ._SENT At_IN 48_CD h_NN posttransfection_NN ,_, proteins_NNS from_IN supernatants_NNS (_( lanes_NNS 2_CD ,_, 4_CD ,_, and_CC 6_CD )_) and_CC cell_NN lysates_NNS (_( lanes_NNS 1_CD ,_, 3_CD ,_, and_CC 5_LS )_) were_VBD immunoprecipitated_VBN using_VBG an_DT anti-FLAG_NN monoclonal_NN antibody_NN ._SENT Immunoblots_NNS of_IN immunoprecipitated_JJ fractions_NNS from_IN mock-transfected_JJ (_( lanes_NNS 1_CD and_CC 2_CD )_) ,_, pTat-Flag-MVV-transfected_JJ (_( lanes_NNS 3_CD and_CC 4_CD )_) ,_, and_CC pTat-Flag-HIV-transfected_JJ (_( lanes_NNS 5_CD and_CC 6_CD )_) cells_NNS were_VBD performed_VBN with_IN a_DT specific_JJ monoclonal_NN antibody_NN directed_VBN against_IN the_DT FLAG_NP epitope_NN ._SENT MVV_NP and_CC CAEV_NP Tat_NP proteins_NNS are_VBP associated_VBN with_IN viral_JJ particles_NNS ._SENT MVV_NP and_CC CAEV_NP Tat_NP proteins_NNS are_VBP associated_VBN with_IN viral_JJ particles_NNS ._SENT TIGEF_NP were_VBD inoculated_VBN (_( MOI_NP ,_, 1_CD )_) with_IN MVV_NP (_( A_NP )_) or_CC CAEV_NP (_( B_NP and_CC C_NP )_) or_CC were_VBD mock_JJ infected_JJ ._SENT At_IN 24_CD h_NN postinoculation_NN ,_, the_DT cells_NNS were_VBD transfected_VBN with_IN pTat-Flag-MVV_NP (_( A_NP )_) and_CC pTat-Flag-CO_NP (_( B_NP and_CC C_NP )_) plasmids_NNS ._SENT At_IN 48_CD h_NN posttransfection_NN ,_, the_DT supernatants_NNS were_VBD collected_VBN and_CC virions_NNS were_VBD harvested_VBN from_IN pellets_NNS by_IN ultracentrifugation_NN ;_: cell_NN lysates_NNS were_VBD then_RB obtained_VBN following_VBG treatment_NN with_IN the_DT lysing_VBG solution_NN ._SENT (_( A_NP and_CC B_NP )_) Proteins_NPS from_IN the_DT supernatants_NNS (_( lanes_NNS 1_CD and_CC 3_CD )_) and_CC cell_NN lysates_NNS (_( lanes_NNS 2_CD and_CC 4_CD )_) were_VBD analyzed_VBN by_IN immunoblot_NN assay_NN by_IN using_VBG an_DT antibody_NN directed_VBN against_IN the_DT FLAG_NP epitope_NN (_( diluted_VBN 10,000_CD times_NNS )_) ._SENT Lanes_NNS 1_CD and_CC 2_CD ,_, cells_NNS infected_VBN with_IN MVV_NP (_( A_NP )_) or_CC CAEV_NP (_( B_NP )_) ;_: lanes_NNS 3_CD and_CC 4_CD ,_, mock-infected_JJ cells_NNS ._SENT (_( C_NP )_) Pellets_NP of_IN virions_NNS were_VBD resuspended_VBN and_CC loaded_VBN on_IN the_DT top_NN of_IN a_DT linear_JJ sucrose_NN gradient_NN ._SENT After_IN 16_CD h_NN of_IN ultracentrifugation_NN ,_, 12_CD fractions_NNS were_VBD collected_VBN and_CC proteins_NNS were_VBD extracted_VBN and_CC then_RB analyzed_VBD by_IN immunoblot_NN assay_NN with_IN an_DT anti-p25_JJ Gag_NP antibody_NN to_TO reveal_VB the_DT major_JJ CAEV_NP capsid_NN protein_NN (_( diluted_VBN 1,000_CD times_NNS )_) or_CC an_DT anti-FLAG_NN antibody_NN (_( diluted_VBN 10,000_CD times_NNS )_) to_TO reveal_VB the_DT CAEV_NP Tat_NP protein_NN ._SENT G2_JJ arrest_NN of_IN cell_NN cycle_NN in_IN Tat-expressing_NP cells_NNS ._SENT G2_JJ arrest_NN of_IN cell_NN cycle_NN in_IN Tat-expressing_NP cells_NNS ._SENT TIGEF_NP were_VBD transfected_VBN with_IN plasmid_NN pGFP_NN as_IN a_DT negative_JJ control_NN or_CC with_IN plasmid_NN pGFP-Tat_NN ._SENT Cells_NNS were_VBD harvested_VBN 72_CD and_CC 120_CD h_NN posttransfection_NN ,_, and_CC the_DT DNA_NN was_VBD stained_VBN with_IN propidium_NN iodide_NN ._SENT Cells_NNS were_VBD analyzed_VBN by_IN flow_NN cytometry_NN of_IN more_JJR than_IN 10,000_CD events_NNS with_IN Cell_NP Quest_NP analysis_NN software_NN ._SENT Histograms_NNS of_IN the_DT flow_NN cytometry_NN analysis_NN of_IN the_DT DNA_NP content_NN in_IN transfected_JJ TIGEF_NP harvested_VBD 72_CD h_NN posttransfection_NN are_VBP shown_VBN in_IN panel_NN A._NP The_DT ordinate_NN indicates_VBZ the_DT number_NN of_IN cells_NNS ,_, and_CC the_DT abscissa_NN indicates_VBZ the_DT DNA_NN content_NN ._SENT (_( B_LS )_) The_DT ratios_NNS of_IN the_DT percentages_NNS of_IN cells_NNS in_IN G2/G1_JJ phases_NNS of_IN the_DT cell_NN cycle_NN are_VBP shown_VBN ._SENT Values_NNS shown_VBN at_IN the_DT top_NN of_IN each_DT bar_NN represent_VBP the_DT mean_JJ value_NN of_IN results_NNS of_IN at_IN least_JJS three_CD independent_JJ transfection_NN experiments_NNS ._SENT Comparison_NN of_IN the_DT primary_JJ structures_NNS of_IN the_DT SRLV_NP and_CC HIV-1_NP Vpr_NP and_CC Tat_NP proteins_NNS ._SENT Comparison_NN of_IN the_DT primary_JJ structures_NNS of_IN the_DT SRLV_NP and_CC HIV-1_NP Vpr_NP and_CC Tat_NP proteins_NNS ._SENT The_DT putative_JJ domains_NNS of_IN MVV_NP Tat_NP ,_, HIV-1_NP Tat_NP ,_, and_CC HIV-1_NP Vpr_NP are_VBP shown_VBN as_IN stained_VBN boxes_NNS ._SENT The_DT HIV-1_NP Tat_NP protein_NN contains_VBZ an_DT N-terminal_JJ proline-rich_JJ domain_NN (_( Pro_NP )_) ,_, a_DT cysteine-rich_JJ domain_NN (_( Cys_NP )_) ,_, a_DT core_NN ,_, a_DT basic_JJ domain_NN (_( basic_JJ )_) ,_, and_CC a_DT glutamine-rich_JJ domain_NN (_( Gln_NP )_) ._SENT The_DT HIV-1_NP Vpr_NP protein_NN contains_VBZ an_DT N-terminal_JJ acidic_JJ domain_NN (_( acidic_JJ )_) ,_, two_CD leucine-rich_JJ domains_NNS (_( Leu_NP )_) ,_, and_CC a_DT basic_JJ domain_NN (_( basic_JJ )_) ._SENT MVV_NP Tat_NP protein_NN contains_VBZ an_DT N-terminal_JJ acidic_JJ domain_NN (_( acidic_JJ )_) ,_, a_DT leucine-rich_JJ domain_NN ,_, and_CC a_DT cysteine-rich_JJ domain_NN ._SENT 